Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,032 $ 4,828
Accounts receivable 4,830 5,032
Other current assets 1,576 2,294
Total current assets 11,438 12,154
Property and equipment, net 762 480
Intangible assets, net 27 861
Operating lease right of use assets 1,978 2,439
Other long-term assets 45 45
Total assets 14,250 15,979
Current liabilities:    
Accounts payable 1,352 1,050
Accrued salary and bonus 1,299 1,456
Other accrued expenses 8,815 8,419
Line of credit - current 2,500
Current liabilities of discontinued operations 858 858
Total current liabilities 12,324 14,283
Contingent consideration 518
Operating lease liabilities, net of current portion 1,556 1,848
Note payable at fair value 11,565 11,165
Other long-term liabilities 4,949 4,701
Total liabilities 30,394 32,515
Commitments and contingencies (Note 9)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,407,492 and 4,367,830 shares issued, respectively; 4,321,772 and 4,296,710 shares outstanding, respectively 405 405
Additional paid-in capital 188,017 187,516
Accumulated deficit (249,105) (249,017)
Treasury stock, at cost (85,720 and 71,120 shares, respectively) (1,997) (1,976)
Total stockholders’ deficit (62,680) (63,072)
Total liabilities and stockholders’ deficit (32,286) (30,557)
Total liabilities, preferred stock and stockholders’ deficit $ 14,250 $ 15,979